Company intelligence
EMJ
Elevating the quality of healthcare globally.
About EMJ
EMJ is the number one open access destination for HCPs and Pharma professionals globally. We do this across 18 therapy areas and the pharmaceutical sector via EMJ GOLD. We use industry-leading digital tools, to meet the challenges of time-poor medical professionals with a real passion to learn and in turn to elevate the quality of healthcare globally. Our content builds trust between healthcare professionals and Pharma, to help them continuously improve together. At the core of our content hub is a portfolio of peer reviewed, open access journals, which are complemented by alternative formats such as interviews, podcasts, webinars, and infographics. We have built our incredible team by recruiting on values. We stay true to these values in everything we do, as we remain steadfast in our goal to create Gold Medal Winners. For trusted partners who share our vision, we invite you to get in touch and join us on our journey. Join our mailing list for FREE to receive the latest news and insights direct to your inbox: https://www.emjreviews.com/mailing-list/
Verified activity
Signals from EMJ
8 published signals
Research & Knowledge
EMJ published new findings suggesting AI-based TIL and spatial analysis could help refine prognosis and identify immune-hot tumours in HER2-positive breast cancer.
Reported by EMJ
Presence & Recognition
EMJ participated in Day 3 of the European Respiratory Society Congress 2026 focusing on the patient experience and breathlessness beyond clinical symptoms.
Reported by EMJ
Presence & Recognition
EMJ reporter Cecilia Adamou reports on Day 2 of the European Respiratory Society Congress 2026 exploring planetary health and lifestyle, and the emerging potential of GLP-1 therapies in respiratory disease.
Reported by EMJ
Research & Knowledge
EMJ published a neurology journal with expert insights from the editorial board including Prof Lászlo Vécsei, Prof Amos Korczyn, Dr Ali Mahmoud Ahmed, and Prof Ranko Raicevic.
Reported by EMJ
Research & Knowledge
EMJ published findings from a recent trial showing that a new at-home urine test successfully identified a significant proportion of bladder cancers.
Reported by EMJ
Presence & Recognition
EMJ published the latest EMJ Podcast series featuring Dr Catherine Glass and Tonia Poteat discussing intersectionality in transgender health.
Reported by EMJ
Presence & Recognition
EMJ employee Jonathan Sackier opened the second day of RISEUK26 at the ICC Birmingham with a keynote reflecting his journey in medical robotics.
Reported by Jonathan Sackier - Innovator, Aviator and Health Commentator
Presence & Recognition
EMJ employee James Murphy is attending the fourth congress of the year, ERS, in Barcelona.
Reported by James Murphy